Generation of a human control iPS cell line (ESi080‐A) from a donor with no rheumatic diseases

Castro Viñuelas, Rocío; Sanjurjo-Rodríguez, Clara; Piñeiro-Ramil, María; Rodríguez-Fernández, Silvia; Fuentes Boquete, Isaac Manuel; Blanco García, Francisco J; Díaz-Prado, Silvia

Use this link to cite:

http://hdl.handle.net/2183/25411

Generation of a human control iPS cell line (ESi080‐A) from a donor with no rheumatic diseases

Files

DiazPrado_2020_Generation_human.pdf (1.5 MB)

DiazPrado_2020_Generation_human_Supplementary_material.pdf (307.16 KB)

DiazPrado_2020_Descripcion_Datasets.pdf (775.59 KB)

DiazPrado_2020_Datasets.zip (2.55 MB)

Identifiers

URI: http://hdl.handle.net/2183/25411

Publication date

2020-03

Authors

Castro Viñuelas, Rocío

Sanjurjo-Rodríguez, Clara

Piñeiro-Ramil, María

Rodríguez-Fernández, Silvia

Fuentes Boquete, Isaac Manuel

Blanco García, Francisco J

Díaz-Prado, Silvia

Bibliographic citation

Castro-Viñuelas R, Sanjurjo-Rodríguez C, Piñeiro-Ramil M, Rodríguez-Fernández S, Fuentes-Boquete IM, Blanco FJ, Díaz-Prado SM. Generation of a human control iPS cell line (ESi080-A) from a donor with no rheumatic diseases. Stem Cell Res. 2020 Mar;43:101683.

Abstract

[Abstract] Here, we report the establishment of the human iPS cell line N1-FiPS4F#7 generated from skin cells of a patient with no rheumatic diseases, thus obtaining an appropriate control iPS cell line for researchers working in the field of rheumatic diseases. The reprogramming factors Oct4, Sox2, Klf4 and c-Myc were introduced using a non-integrating reprogramming strategy involving Sendai Virus.